Your shopping cart is currently empty

COX-2-IN-20 (Compound 5d) is a selective and orally active COX-2 inhibitor (IC50 = 17.9 nM) with anti-inflammatory activity [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | COX-2-IN-20 (Compound 5d) is a selective and orally active COX-2 inhibitor (IC50 = 17.9 nM) with anti-inflammatory activity [1]. |
| Targets&IC50 | COX-1:19.3 μM, COX-2:17.9 nM |
| In vitro | COX-2-IN-20 (Compound 5d) exhibits potential anti-inflammatory activity, inhibiting NO production in LPS-induced RAW 264.7 cells with an IC50 of 2.87 μM [1]. |
| In vivo | COX-2-IN-20 (Compound 5d) (5 mg/kg) demonstrates superior anti-inflammatory and gastric protective effects in vivo compared to 10 mg/kg indomethacin [1]. |
| Molecular Weight | 269.66 |
| Formula | C11H9ClFN3O2 |
| Cas No. | 2529451-43-0 |
| Smiles | C(Cl)C=1N(N=C(C(OC)=O)N1)C2=CC=C(F)C=C2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.